Ignite Creation Date:
2025-12-24 @ 9:43 PM
Ignite Modification Date:
2026-01-04 @ 4:44 AM
Study NCT ID:
NCT00016432
Status:
COMPLETED
Last Update Posted:
2011-04-19
First Post:
2001-05-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
Sponsor:
NSABP Foundation Inc
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
NSABP B-33
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Norman Wolmark, MD
Old Organization:
NSABP Foundation, Inc.
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |